BioNTech SE
(NAS:BNTX)
$
86.61
1.97 (2.33%)
Market Cap: 20.87 Bil
Enterprise Value: 4.10 Bil
PE Ratio: 174.62
PB Ratio: 0.95
GF Score: 66/100 - Q1 2024 BioNTech SE Earnings Call TranscriptMay 06, 2024$93.35 (+0.68%)Earnings
- Q4 2023 BioNTech SE Earnings Call TranscriptMar 20, 2024$90 (-4.38%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- BioNTech SE Inaugurates its First African Site in Kigali TranscriptDec 18, 2023
- BioNTech SE Capital Markets Day TranscriptNov 07, 2023
- Q3 2023 BioNTech SE Earnings Call TranscriptNov 06, 2023$99.71 (+4.10%)Earnings
- Q2 2023 BioNTech SE Earnings Call TranscriptAug 07, 2023$98.5 (-7.49%)Earnings
- Q1 2023 BioNTech SE Earnings Call TranscriptMay 08, 2023$108.05 (-0.35%)Earnings
- Q4 2022 BioNTech SE Earnings Call TranscriptMar 27, 2023$123.6 (-3.59%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 BioNTech SE Earnings Call TranscriptNov 07, 2022$160.72 (+4.15%)Earnings
- Q2 2022 BioNTech SE Earnings Call TranscriptAug 08, 2022$169.3 (-7.54%)Earnings
- BioNTech SE To Discuss on Host First Edition of Innovation Series on Diversified Pipeline, Latest Technology Innovations Call TranscriptJun 29, 2022
- Q1 2022 BioNTech SE Earnings Call TranscriptMay 09, 2022$140.32 (+3.05%)Earnings
- Q4 2021 BioNTech SE Earnings Call TranscriptMar 30, 2022$174.78 (+1.39%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 11, 2022
- BioNTech SE To Discuss Hold Digital Press Conference to Provide an Update on Omicron Variant Call TranscriptDec 08, 2021
- Q3 2021 BioNTech SE Earnings Call TranscriptNov 09, 2021$226.37 (-6.69%)Earnings
- Q2 2021 BioNTech SE Earnings Call TranscriptAug 09, 2021$447.23 (+14.97%)Earnings
- BioNTech SE at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- BioNTech SE at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- BioNTech SE at UBS Global Healthcare Virtual Conference TranscriptMay 26, 2021
- Q1 2021 BioNTech SE Earnings Call TranscriptMay 10, 2021$202.35 (+10.15%)Earnings
- BioNTech SE at JPMorgan NAPA Valley Forum (Virtual) TranscriptMar 31, 2021
- Q4 2020 BioNTech SE Earnings Call TranscriptMar 30, 2021$104.44 (+8.89%)Earnings
- BioNTech SE at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 24, 2021
- BioNTech SE at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 BioNTech SE Earnings Call TranscriptNov 10, 2020$112.76 (+7.60%)Earnings
- Q2 2020 BioNTech SE Earnings Call TranscriptAug 11, 2020$68.45 (-7.44%)Earnings
- BioNTech SE To Present Early Positive Data From Ongoing Phase 1/2 Study of mRNA-Based Vaccine Candidate Against SARS-CoV-2 Call TranscriptJul 01, 2020
- BioNTech SE at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- BioNTech SE at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 BioNTech SE Earnings Call TranscriptMay 12, 2020$49.33 (-1.30%)Earnings
- BioNTech SE - Special Call TranscriptApr 23, 2020
- Full Year 2019 BioNTech SE Earnings Call TranscriptMar 31, 2020$58.4 (-5.81%)Earnings
- BioNTech SE at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 BioNTech SE Earnings Call TranscriptNov 14, 2019$19 (+2.43%)Earnings
BioNTech SE at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021 / 03:50PM GMT
Release Date Price:
$108.9
(+8.48%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst
Great. Good morning, everyone, from the Virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company, BioNTech, and CEO and Co-Founder, Ugur Sahin.
Please note that following this presentation, we will have a Q&A session right here in this Zoom room where you're also able to submit questions via the little blue ask-a-question button in your conference portal.
So with that, Ugur, thank you so much for being here today. Very interested in this discussion. So let me turn things over to you to get started.
Ugur Sahin
BioNTech SE - Co-Founder, CEO & Member of Management Board
Thank you, Cory. Can you hear me?
Cory William Kasimov;Ugur Sahin
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst;BioNTech SE - Co-Founder, CEO & Member of
Yes.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)